Guidelines on the irritable bowel syndrome: mechanisms and practical management
暂无分享,去创建一个
R Jones | Q Aziz | P. Whorwell | R. Spiller | Q. Aziz | L. Houghton | A. Emmanuel | F. Creed | N. Trudgill | Roger H Jones | F. Creed | G. Rubin | G Rubin | R. Jones | P Hungin | A Emmanuel | F Creed | D Kumar | R Spiller | P Whorwell | L Houghton | N Trudgill | D. Kumar | P. Hungin | G. Rubin | Qasim Aziz | A. Emmanuel
[1] N. D. de Wit,et al. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. , 2005, The Cochrane database of systematic reviews.
[2] D. Thompson,et al. Health-Related Quality of Life and Health Care Costs in Severe, Refractory Irritable Bowel Syndrome , 2001, Annals of Internal Medicine.
[3] R. Spiller. Effects of serotonin on intestinal secretion and motility. , 2001, Current opinion in gastroenterology.
[4] T. Stephenson,et al. A primary care cross-sectional study of undiagnosed adult coeliac disease , 2003, European journal of gastroenterology & hepatology.
[5] A. Morelli,et al. Functional gut disorders and health care seeking behavior in an Italian non-patient population. , 1989, Recenti progressi in medicina.
[6] E. Irvine,et al. Functional Gastrointestinal Disorders in Canada: First Population-Based Survey Using Rome II Criteria with Suggestions for Improving the Questionnaire , 2004, Digestive Diseases and Sciences.
[7] C. L. Kwan,et al. Abnormal rectal motor physiology in patients with irritable bowel syndrome , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[8] E. Bjornsson,et al. Abnormal Propagation Pattern of Duodenal Pressure Waves in the Irritable Bowel Syndrome (IBS) , 2000, Digestive Diseases and Sciences.
[9] P. Whorwell,et al. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. , 2006, Gastroenterology.
[10] Thomas A Trikalinos,et al. Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.
[11] C. O'boyle,et al. A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease , 1991, Acta psychiatrica Scandinavica.
[12] M. Camilleri,et al. Efficacy of alosetron in irritable bowel syndrome: a meta‐analysis of randomized controlled trials , 2003, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[13] J. Chastang,et al. Does lactose maldigestion really play a role in the irritable bowel? , 1996, Journal of clinical gastroenterology.
[14] J. Ritchie. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome 1 , 1973, Gut.
[15] B. Shuter,et al. Gastroparesis and Small Bowel Dysmotility in Irritable Bowel Syndrome , 1997, Digestive Diseases and Sciences.
[16] D. Drossman. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? , 1999, The American journal of medicine.
[17] E. Blanchard,et al. Psychopathology in Irritable Bowel Syndrome: Support for a Psychophysiological Model , 2003, Journal of Behavioral Medicine.
[18] A. Nielsen,et al. Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study. , 1987, Scandinavian journal of gastroenterology. Supplement.
[19] M. Debakey,et al. Hypnosis and Irritable Bowel Syndrome: A Review of Efficacy and Mechanism of Action , 2005, The American journal of clinical hypnosis.
[20] L. Melton,et al. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. , 1995, American journal of epidemiology.
[21] Songkai Yan,et al. Impact of Irritable Bowel Syndrome on Quality of Life and Resource Use in the United States and United Kingdom , 1999, Digestion.
[22] Shara I. Feld,et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. , 2001, Gastroenterology.
[23] P. Whorwell,et al. Physiological effects of emotion: assessment via hypnosis , 1992, The Lancet.
[24] Henry C. Lin,et al. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome , 2000, American Journal of Gastroenterology.
[25] H. Stankiewicz,et al. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. , 2000, The Israel Medical Association journal : IMAJ.
[26] Gulzar Singh,et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] C. Ciacci,et al. Fibromyalgia in patients with irritable bowel syndrome , 2001, International Journal of Colorectal Disease.
[28] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[29] G. Gasbarrini,et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. , 1992, The American journal of gastroenterology.
[30] P. Whorwell,et al. CONTROLLED TRIAL OF HYPNOTHERAPY IN THE TREATMENT OF SEVERE REFRACTORY IRRITABLE-BOWEL SYNDROME , 1984, The Lancet.
[31] S. Derbyshire. A systematic review of neuroimaging data during visceral stimulation. , 2003 .
[32] E. Björnsson,et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress , 2004, Gut.
[33] A. Kennedy,et al. Incorporating patients' views and experiences of life with IBS in the development of an evidence based self-help guidebook. , 2003, Patient education and counseling.
[34] M. Camilleri,et al. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. , 1997, The American journal of gastroenterology.
[35] R. Spiller. Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective. , 2003 .
[36] N. Talley,et al. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia , 2004, Gut.
[37] M. Camilleri,et al. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. , 2005, Gastroenterology clinics of North America.
[38] P. Whorwell,et al. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome , 2000, Gut.
[39] P. Whorwell,et al. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.
[40] B. Birkenfeld,et al. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome , 2001, European journal of gastroenterology & hepatology.
[41] L. Melton,et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome , 2000, American Journal of Gastroenterology.
[42] M. Bots,et al. Functional bowel symptoms in a general Dutch population and associations with common stimulants. , 2001, The Netherlands journal of medicine.
[43] M. Camilleri,et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. , 1991, Gastroenterology.
[44] J. Knottnerus,et al. The diagnostic value of rectal examination. , 1993, Family practice.
[45] D. J. Deller,et al. Intestinal motility in man. IV. Effect of serotonin on intestinal motility in subjects with diarrhea and constipation. , 1966, Gastroenterology.
[46] B. Dean,et al. Impairment in work productivity and health-related quality of life in patients with IBS. , 2005, The American journal of managed care.
[47] A R Zinsmeister,et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. , 1991, Gastroenterology.
[48] P. Whorwell,et al. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[49] P. Whorwell,et al. Diagnostic Criteria for Irritable Bowel Syndrome: Utility and Applicability in Clinical Practice , 2005, Digestion.
[50] K W Heaton,et al. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral , 2000, Gut.
[51] J. Misiewicz,et al. Comparison of the effect of meals and prostigmine on the proximal and distal colon in patients with and without diarrhoea. , 1966, Gut.
[52] C. Chew‐Graham,et al. Framing the doctor-patient relationship in chronic illness: a comparative study of general practitioners' accounts. , 2004, Sociology of health & illness.
[53] J. Malagelada,et al. Lipid-induced intestinal gas retention in irritable bowel syndrome. , 2002, Gastroenterology.
[54] R. Wasserman,et al. The irritable colon of childhood (chronicnonspecific diarrhea syndrome) , 1966 .
[55] E A Mayer,et al. Regional cerebral activity in normal and pathological perception of visceral pain. , 1997, Gastroenterology.
[56] J. Tack,et al. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome , 2005, Gut.
[57] L. Chang,et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact , 2005, Alimentary pharmacology & therapeutics.
[58] Henry C. Lin,et al. Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study , 2003, American Journal of Gastroenterology.
[59] E. Spitznagel,et al. The presentation of irritable bowel syndrome in the context of somatization disorder. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[60] H. J. McQuay,et al. A systematic review of antidepressants in neuropathic pain , 1996, Pain.
[61] R. Harvey,et al. PROGNOSIS IN THE IRRITABLE BOWEL SYNDROME: A 5-YEAR PROSPECTIVE STUDY , 1987, The Lancet.
[62] P. Whorwell,et al. Tegaserod for the treatment of irritable bowel syndrome. , 2004, The Cochrane database of systematic reviews.
[63] M. Hongo,et al. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome , 1998, Gut.
[64] James N. Campbell,et al. Peripheral and central mechanisms of cutaneous hyperalgesia , 1992, Progress in Neurobiology.
[65] I. Wiklund,et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials , 2001, Alimentary pharmacology & therapeutics.
[66] Burns Dg. The risk of abdominal surgery in irritable bowel syndrome. , 1986 .
[67] H. Meshkinpour,et al. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. , 1988, Gastroenterology.
[68] T. Nomura,et al. Abnormal electroencephalogram in irritable bowel syndrome. , 1999, Scandinavian journal of gastroenterology.
[69] J. Malagelada,et al. Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating. , 2006, Gastroenterology.
[70] F. De Ponti. Pharmacology of serotonin: what a clinician should know , 2004, Gut.
[71] N. Talley,et al. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? , 2000, American Journal of Gastroenterology.
[72] M. Davidson,et al. The iritable colon of childhood (chronic nonspecific diarrhea syndrome). , 1966, The Journal of pediatrics.
[73] M. Elia,et al. Abnormal colonic fermentation in irritable bowel syndrome , 1998, The Lancet.
[74] P. Whorwell,et al. Non-colonic features of irritable bowel syndrome. , 1986, Gut.
[75] Review article: the history of hypnotherapy and its role in the irritable bowel syndrome , 2005, Alimentary pharmacology & therapeutics.
[76] D. Jewell,et al. Food intolerance and the irritable bowel syndrome. , 1989, Gut.
[77] P. Schoenfeld,et al. The epidemiology of irritable bowel syndrome in North America: a systematic review , 2002, American Journal of Gastroenterology.
[78] G. Deakin. Behavioural psychotherapy. , 1983, Nursing mirror.
[79] A. Ruigómez,et al. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study , 1999, BMJ.
[80] A. Mangel,et al. Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey , 2005, Alimentary pharmacology & therapeutics.
[81] I. Trotman,et al. Sigmoid motility in diverticular disease and the irritable bowel syndrome. , 1988, Gut.
[82] W. Paterson,et al. Predictive value of the rome criteria for diagnosing the irritable bowel syndrome , 1999, American Journal of Gastroenterology.
[83] E. Mayer,et al. Alosetron and irritable bowel syndrome , 2003, Expert opinion on pharmacotherapy.
[84] E A Mayer,et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. , 1997, Gastroenterology.
[85] P. Whorwell,et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? , 2003, Gut.
[86] G. Lux,et al. Myoelectric and manometric patterns of human rectosigmoid colon in irritable bowel syndrome and diverticulosis. , 1990, Scandinavian journal of gastroenterology.
[87] W. Whitehead,et al. Increased Somatic Complaints and Health-Care Utilization in Children: Effects of Parent IBS Status and Parent Response to Gastrointestinal Symptoms , 2004, American Journal of Gastroenterology.
[88] R. Spitzer,et al. The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms , 2002, Psychosomatic medicine.
[89] H. Torebjörk,et al. Central changes in processing of mechanoreceptive input in capsaicin‐induced secondary hyperalgesia in humans. , 1992, The Journal of physiology.
[90] F. Creed,et al. Functional abdominal pain, psychiatric illness, and life events. , 1988, Gut.
[91] B. Scott,et al. Painful rib syndrome--a review of 76 cases. , 1993, Gut.
[92] R. Newell,et al. Behavioural psychotherapy in the treatment of irritable bowel syndrome. , 1991, Journal of psychosomatic research.
[93] G. Chrousos,et al. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[94] P. Whorwell,et al. Long term benefits of hypnotherapy for irritable bowel syndrome , 2003, Gut.
[95] K. Bodger,et al. Clinical economics review: medical management of inflammatory bowel disease , 1999, Alimentary pharmacology & therapeutics.
[96] G. Bodemar,et al. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhoea, constipation and symptom variation during a prospective 6‐week study , 1998, European journal of gastroenterology & hepatology.
[97] I. Penman,et al. Symptom interpretation and quality of life in patients with irritable bowel syndrome. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.
[98] T. Abell,et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. , 1994, Gastroenterology.
[99] N. Kerse,et al. Is Physical Activity Counseling Effective for Older People? A Cluster Randomized, Controlled Trial in Primary Care , 2005, Journal of the American Geriatrics Society.
[100] B. Koes,et al. Health status and management of chronic non-specific abdominal complaints in general practice. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.
[101] G. Harinath,et al. ``Rectal hypersensitivity in the irritable bowel syndrome'' , 1997, International Journal of Colorectal Disease.
[102] J. Barkin. The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial , 2007 .
[103] A. Smout,et al. Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. , 1992, Scandinavian journal of gastroenterology.
[104] W. Katon,et al. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. , 1996, Journal of psychosomatic obstetrics and gynaecology.
[105] X. Badia,et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. , 2001, Scandinavian journal of gastroenterology.
[106] H. Birnbaum,et al. The economic consequences of irritable bowel syndrome: a US employer perspective. , 2003, Archives of internal medicine.
[107] R. Heading,et al. Heightened visceral sensation in functional gastrointestinal disease is not site-specific , 1995, Digestive Diseases and Sciences.
[108] C. Böhmer,et al. The clinical relevance of lactose malabsorption in irritable bowel syndrome , 1996, European journal of gastroenterology & hepatology.
[109] Therapeutic value of a gastroenterology consultation in irritable bowel syndrome , 2003, Alimentary pharmacology & therapeutics.
[110] E A Mayer,et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. , 1995, Gastroenterology.
[111] G. Longstreth,et al. Chronic abdominal wall pain: clinical features, health care costs, and long-term outcome. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[112] M. Kamm,et al. Laser Doppler measurement of rectal mucosal blood flow , 1999, Gut.
[113] E. Blanchard,et al. Prediction of outcome from the self-regulatory treatment of irritable bowel syndrome. , 1988, Behaviour research and therapy.
[114] P. O'Malley,et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. , 1999, The Journal of family practice.
[115] A. Williams,et al. Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. , 1991, Gut.
[116] T. Spector,et al. Genetic Influences in Irritable Bowel Syndrome: A Twin Study , 2005, The American Journal of Gastroenterology.
[117] T. Sheldon,et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial , 2004, Gut.
[118] M. Camilleri,et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. , 2002, Gastroenterology.
[119] J. Geddes,et al. What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.
[120] J. Barton,et al. Is lactose intolerance implicated in the development of post-infectious irritable bowel syndrome or functional diarrhoea in previously asymptomatic people? , 2002, European journal of gastroenterology & hepatology.
[121] S. Wessely,et al. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial , 2005, BMJ : British Medical Journal.
[122] J. Malagelada,et al. Prokinetic effects in patients with intestinal gas retention. , 2002, Gastroenterology.
[123] J. Mclaughlin,et al. The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome , 2006, Expert opinion on drug safety.
[124] A. Taylor,et al. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. , 1992, Behaviour research and therapy.
[125] M. Samsom,et al. Association between pain episodes and high amplitude propagated pressure waves in patients with irritable bowel syndrome , 2003, American Journal of Gastroenterology.
[126] R. Spiller. Postinfectious irritable bowel syndrome. , 2003, Gastroenterology.
[127] B. Flourié,et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation , 1999, Gut.
[128] S. Lu,et al. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling. , 2000, Chinese medical journal.
[129] M. Cheang,et al. Defining the predictors of the placebo response in irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[130] W. Chey,et al. Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome , 2004, The American Journal of Gastroenterology.
[131] M. C. Reilly,et al. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation , 2005, Alimentary pharmacology & therapeutics.
[132] M. Vermeeren,et al. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. , 1990, Gastroenterology.
[133] M. Gershon. Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel , 1999, Alimentary pharmacology & therapeutics.
[134] S. Sherman,et al. Functional gallbladder and sphincter of oddi disorders. , 2006, Gastroenterology.
[135] P. Whorwell,et al. Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome , 2006, The American Journal of Gastroenterology.
[136] A. Zinsmeister,et al. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. , 1995, Digestive diseases and sciences.
[137] P. Whorwell,et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects , 2003, Alimentary pharmacology & therapeutics.
[138] R. Kessler,et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. , 2000, Gastroenterology.
[139] D. Drossman,et al. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. , 1982, Gastroenterology.
[140] The role of psychological and biological factors in postinfective gut dysfunction , 1999 .
[141] A. Sperber,et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia , 2000, American Journal of Gastroenterology.
[142] H. Verspaget,et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. , 2005, The American journal of gastroenterology.
[143] H. Sloth,et al. Chronic non-organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study. , 1988, Scandinavian journal of gastroenterology.
[144] L. Melton,et al. Overlap of gastrointestional symptom complexes in a US community , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[145] P. Spreeuwenberg,et al. Patients with irritable bowel syndrome: health status and use of health care services. , 1999, The British journal of general practice : the journal of the Royal College of General Practitioners.
[146] G. Andrews,et al. Evidence of a Genetic Contribution to Functional Bowel Disorder , 1998, American Journal of Gastroenterology.
[147] B. Yawn,et al. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population , 2004, Alimentary pharmacology & therapeutics.
[148] P. Whorwell,et al. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. , 2006, Gastroenterology.
[149] P. Scully,et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? , 2006, Gastroenterology.
[150] D. Barends,et al. Role of loperamide and placebo in management of irritable bowel syndrome (IBS) , 1984, Digestive Diseases and Sciences.
[151] R. Kessler,et al. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. , 1995, Archives of general psychiatry.
[152] Y. Taché,et al. CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats , 2005, Gut.
[153] E A Mayer,et al. Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome. , 1998, Journal of psychosomatic research.
[154] J. Willer,et al. Diffuse Noxious Inhibitory Controls (DNIC) , 2008 .
[155] G. Sturniolo,et al. [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.
[156] E. Zamble,et al. A controlled behavioral treatment study of Irritable Bowel syndrome , 1989 .
[157] K. Ho,et al. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms , 1998, American Journal of Gastroenterology.
[158] S. Caras,et al. CILANSETRON IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA PREDOMINANCE (IBS-D): EFFICACY AND SAFETY IN A 3 MONTH US STUDY , 2004 .
[159] G. Gebhart,et al. Role of sensitized pelvic nerve afferents from the inflamed rat colon in the maintenance of visceral hyperalgesia. , 2000, Progress in brain research.
[160] M. A. Masud,et al. Irritable bowel syndrome in a rural community in Bangladesh: Prevalence, symptoms pattern, and health care seeking behavior , 2001, American Journal of Gastroenterology.
[161] T. Poynard,et al. Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome , 2001, Alimentary pharmacology & therapeutics.
[162] D. Drossman,et al. Identification of sub-groups of functional gastrointestinal disorders , 1990 .
[163] M. Merrick,et al. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. , 1985, British medical journal.
[164] N. Talley,et al. Are adverse food reactions linked to irritable bowel syndrome? , 1998, American Journal of Gastroenterology.
[165] F. Shanahan,et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. , 2005, Gastroenterology.
[166] I. Tracey,et al. Cortical Processing of Human Somatic and Visceral Sensation , 1999, The Journal of Neuroscience.
[167] W. Rathmann,et al. Prevalence of Functional Bowel Disorders and Related Health Care Seeking: A Population-Based Study , 2002, Zeitschrift fur Gastroenterologie.
[168] D L Wingate,et al. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. , 1990, Gastroenterology.
[169] Foster,et al. Alosetron, a 5‐HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers , 2000, Alimentary pharmacology & therapeutics.
[170] Roger Jones,et al. Irritable bowel syndrome in the general population. , 1992, BMJ.
[171] M. Camilleri,et al. Colonic tone and motility in patients with irritable bowel syndrome. , 1992, Mayo Clinic proceedings.
[172] P. Vandvik,et al. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case‐control study , 2004, Scandinavian journal of gastroenterology.
[173] R. Sandler,et al. Prevalence and Characteristics of Irritable Bowel Syndrome Among Women With Chronic Pelvic Pain , 2004, Obstetrics and gynecology.
[174] Michael P. Jones,et al. A systematic review of alternative therapies in the irritable bowel syndrome. , 2003, Archives of internal medicine.
[175] I. Wiklund,et al. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials , 2005, European journal of gastroenterology & hepatology.
[176] J. Llovet,et al. Sugar malabsorption in functional bowel disease: clinical implications. , 1993, The American journal of gastroenterology.
[177] G. Bleijenberg,et al. Cognitive-Behavioral Group Therapy for Irritable Bowel Syndrome: Effects and Long-Term Follow-Up , 1996, Psychosomatic medicine.
[178] T. Jørgensen,et al. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors , 1994, Journal of internal medicine.
[179] G. Boeckxstaens,et al. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[180] S. Fullerton,et al. Effect of Amitryptiline on Symptoms, Sleep, and Visceral Perception in Patients With Functional Dyspepsia , 1998, American Journal of Gastroenterology.
[181] J. Munakata,et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. , 1994, Gastroenterology.
[182] A. Zinsmeister,et al. Dysmotility of the small intestine in irritable bowel syndrome. , 1988, Gut.
[183] T. Kennedy,et al. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population , 2000, The British journal of surgery.
[184] M. Delvaux,et al. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome , 1998, Alimentary pharmacology & therapeutics.
[185] P. Gumowski,et al. Irritable bowel syndrome and hypersensitivity to food. , 1985, Annals of allergy.
[186] D. Sanders,et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care , 2001, The Lancet.
[187] M. Benson,et al. Food-Specific Serum IgG4 and IgE Titers to Common Food Antigens in Irritable Bowel Syndrome , 2005, The American Journal of Gastroenterology.
[188] L. Melton,et al. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. , 2004, Mayo Clinic proceedings.
[189] A. Riordan,et al. Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet , 1995 .
[190] M. Mckendrick. Post Salmonella irritable bowel syndrome--5 year review. , 1996, The Journal of infection.
[191] K. Kip,et al. Crohn's Disease: A Two-Year Prospective Study of the Association Between Psychological Distress and Disease Activity , 2004, Digestive Diseases and Sciences.
[192] B. Naliboff,et al. Irritable Bowel Syndrome Patients Show Enhanced Modulation of Visceral Perception by Auditory Stress , 2003, American Journal of Gastroenterology.
[193] J. Svedlund,et al. CONTROLLED STUDY OF PSYCHOTHERAPY IN IRRITABLE BOWEL SYNDROME , 1983, The Lancet.
[194] P. Enck,et al. The placebo response in functional bowel disorders: perspectives and putative mechanisms , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[195] P. O'Malley,et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. , 2000, The American journal of medicine.
[196] O. Nyrén,et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. , 1995, Gastroenterology.
[197] M. Mendall,et al. Antibiotics increase functional abdominal symptoms , 2002, American Journal of Gastroenterology.
[198] W. Whitehead,et al. Intergenerational transmission of gastrointestinal illness behavior , 2000, American Journal of Gastroenterology.
[199] L. D. O'Donnell,et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. , 1992, Gastroenterology.
[200] J. Kellow,et al. Functional gastrointestinal disorders: psychological, social, and somatic features , 1998, Gut.
[201] W. Clark,et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario , 2004, Alimentary pharmacology & therapeutics.
[202] M. Eastwood,et al. Life events, psychiatric illness and the irritable bowel syndrome. , 1987, Gut.
[203] H. Mönnikes,et al. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome , 2000, American Journal of Gastroenterology.
[204] G. Bleijenberg,et al. Doctor-dependent changes in complaint-related cognitions and anxiety during medical consultations in functional abdominal complaints , 1995, Psychological Medicine.
[205] N. Afdhal,et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. , 2006, Gastroenterology.
[206] A. Zinsmeister,et al. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates , 2000, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[207] J. Kellow,et al. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. , 1987, Gastroenterology.
[208] H. Testa,et al. Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine , 1998, Alimentary pharmacology & therapeutics.
[209] M. Camilleri,et al. Effect of a 5HT3‐antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome , 1993, Alimentary pharmacology & therapeutics.
[210] K W Heaton,et al. Functional bowel disorders and functional abdominal pain , 1999, Gut.
[211] C. L. Kwan,et al. Characteristics of rectal perception are altered in irritable bowel syndrome , 2005, Pain.
[212] E. Blanchard,et al. Relaxation training as a treatment for irritable bowel syndrome , 1993, Biofeedback and self-regulation.
[213] D. Duerksen,et al. Post-Traveler's Diarrhea Irritable Bowel Syndrome: A Prospective Study , 2003, American Journal of Gastroenterology.
[214] A. Zinsmeister,et al. Familial aggregation of irritable bowel syndrome: a prospective study , 2003, Gut.
[215] J. Bohr,et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Örebro, Sweden, 1993–1998 , 2004, Gut.
[216] R. Spiller,et al. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients , 1997, BMJ.
[217] G. Barbara,et al. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome , 2002, American Journal of Gastroenterology.
[218] N. Talley,et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. , 1998, JAMA.
[219] M. Kamm,et al. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. , 2004, Gastroenterology.
[220] A. Blum,et al. Meta‐analysis: the treatment of irritable bowel syndrome , 2004, Alimentary pharmacology & therapeutics.
[221] F. Simoons,et al. The geographic hypothesis and lactose malabsorption , 1978, The American Journal of Digestive Diseases.
[222] E. Quigley,et al. Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder? , 1993, Digestive Diseases and Sciences.
[223] Behavioral medicine approaches to gastrointestinal disorders. , 1992, Journal of consulting and clinical psychology.
[224] W. Whitehead,et al. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? , 2002, Gastroenterology.
[225] N. Talley,et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study , 2001, American Journal of Gastroenterology.
[226] P. Whorwell,et al. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. , 2004, Journal of psychosomatic research.
[227] C. Penning, J. Steens, P. J. van der Schaar, J. Ku. Motor and Sensory Function of the Rectum in Different Subtypes of Constipation , 2001 .
[228] M. Camilleri,et al. Challenges in drug development for functional gastrointestinal disorders. Part II: Visceral pain , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[229] R. Spiller,et al. Randomized, double‐blind, placebo‐controlled trial of prednisolone in post‐infectious irritable bowel syndrome , 2003, Alimentary pharmacology & therapeutics.
[230] L Bueno,et al. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. , 1997, Gastroenterology.
[231] C. Segebarth,et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study , 2002, American Journal of Gastroenterology.
[232] W. Whitehead,et al. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. , 1992, Gut.
[233] G. Holtmann,et al. Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial , 2004, Alimentary pharmacology & therapeutics.
[234] B. Hahn,et al. Irritable Bowel Syndrome Symptom Patterns: Frequency, Duration, and Severity , 1998, Digestive Diseases and Sciences.
[235] R. Poulton,et al. The Natural History of Childhood Abdominal Pain and its Association with Adult Irritable Bowel Syndrome: Birth-Cohort Study , 2005, The American Journal of Gastroenterology.
[236] L. Melton,et al. Psychosocial Factors are Linked to Functional Gastrointestinal Disorders: A Population Based Nested Case-Control Study , 2004, American Journal of Gastroenterology.
[237] R. Chapman,et al. Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double‐blind, randomized, placebo‐controlled trial , 2002, Alimentary pharmacology & therapeutics.
[238] J. I. WAND-TETLEY. Historical methods of counter-irritation. , 1956, Annals of physical medicine.
[239] N. Read,et al. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. , 1983, Gut.
[240] J. Galmiche,et al. Changes in chemical coding of myenteric neurones in ulcerative colitis , 2003, Gut.
[241] R. Bolus,et al. Characterization of the Alternating Bowel Habit Subtype in Patients with Irritable Bowel Syndrome , 2005, The American Journal of Gastroenterology.
[242] S. Morley,et al. Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey , 1997, BMJ.
[243] D. J. Deller,et al. INTESTINAL MOTILITY IN MAN. 3. MECHANISMS OF CONSTIPATION AND DIARRHEA WITH PARTICULAR REFERENCE TO THE IRRITABLE COLON SYNDROME. , 1965, Gastroenterology.
[244] Hiroaki Kumano,et al. Comorbidity of Irritable Bowel Syndrome, Panic Disorder, and Agoraphobia in a Japanese Representative Sample , 2004, American Journal of Gastroenterology.
[245] H. Verspaget,et al. Role of Tumor Necrosis Factor-α and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome , 2005, The American Journal of Gastroenterology.
[246] J. Misiewicz,et al. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. , 1989, Gut.
[247] J. Tack,et al. Impact of Coexisting Irritable Bowel Syndrome on Symptoms and Pathophysiological Mechanisms in Functional Dyspepsia , 2004, American Journal of Gastroenterology.
[248] D. Drossman,et al. unctional Abdominal Pain Syndrome , 2006 .
[249] A. Haines,et al. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care? , 2002, BMJ : British Medical Journal.
[250] P. Whorwell,et al. Irritable bowel syndrome in the gynecological clinic , 1989, Digestive diseases and sciences.
[251] J André Knottnerus,et al. Evaluation of diagnostic procedures , 2002, BMJ : British Medical Journal.
[252] J. Hipólito,et al. [Anthropo-analytical relaxation in irritable bowel syndrome: results 40 months later]. , 1987, Schweizerische medizinische Wochenschrift.
[253] J. Svedlund. Psychotherapy in irritable bowel syndrome. A controlled outcome study. , 1983, Acta psychiatrica Scandinavica. Supplementum.
[254] P. Whorwell,et al. Double blind study of ispaghula in irritable bowel syndrome. , 1987, Gut.
[255] A. Hobson,et al. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? , 2004, Gut.
[256] Anthony H. Dickenson,et al. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat , 1979, PAIN.
[257] J Melke,et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. , 2001, American journal of medical genetics.
[258] G. Koch,et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. , 2003, Gastroenterology.
[259] K. Lüttecke. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome. , 1980, Current medical research and opinion.
[260] D. Drossman,et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. , 1988, Gastroenterology.
[261] Ehsanullah,et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients , 1999, Alimentary pharmacology & therapeutics.
[262] J. B. Vancouver,et al. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. , 1990, Gastroenterology.
[263] C. Woolf,et al. Somatic pain--pathogenesis and prevention. , 1995, British journal of anaesthesia.
[264] J. Llovet,et al. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome , 1991 .
[265] Schütz,et al. A double‐blind, randomized, placebo‐controlled dose‐ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome , 2000, Alimentary pharmacology & therapeutics.
[266] N Kerse,et al. Effect of the addition of a “help” question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study , 2005, BMJ : British Medical Journal.
[267] E. Guthrie. Brief Psychotherapy with Patients with Refractory Irritable Bowel Syndrome , 1991 .
[268] A. Morelli,et al. Colonic motility and gastric emptying in patients with irritable bowel syndrome effect of pretreatment with octylonium bromide , 1986, Digestive Diseases and Sciences.
[269] A. Read,et al. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. , 1973, Lancet.
[270] F. Cuccurullo,et al. Visceral Sensitivity and Symptoms in Patients with Constipation- or Diarrhea-predominant Irritable Bowel Syndrome (IBS): Effect of a Low-Fat Intraduodenal Infusion , 2005, The American Journal of Gastroenterology.
[271] D. Spiegelhalter,et al. Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.
[272] F. Mearin,et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. , 2005, Gastroenterology.
[273] S. Patten,et al. Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[274] D. McGill,et al. Irritable bowel syndrome. Role of lactase deficiency. , 1983, Mayo Clinic proceedings.
[275] P. Whorwell,et al. Clinical economics review: irritable bowel syndrome , 1997, Alimentary pharmacology & therapeutics.
[276] T. Abell,et al. Effect of Leuprolide Acetate in Treatment of Abdominal Pain and Nausea in Premenopausal Women with Functional Bowel Disease: A Double-Blind, Placebo-Controlled, Randomized Study , 1998, Digestive Diseases and Sciences.
[277] P. Whorwell,et al. High Prevalence of Irritable Bowel Syndrome in Patients Attending Urological Outpatient Departments , 1997, Digestive Diseases and Sciences.
[278] M. Benson,et al. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome , 2005, Scandinavian journal of gastroenterology.
[279] P. Whorwell,et al. Bran and irritable bowel syndrome: time for reappraisal , 1994, The Lancet.
[280] T. King. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. , 1996, Clinical nutrition.
[281] P. Whorwell,et al. Gut‐focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome , 2003, Alimentary pharmacology & therapeutics.
[282] N. Talley,et al. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: A critical review of the literature on symptom and psychosocial factors , 2001, American Journal of Gastroenterology.
[283] R. Spiller,et al. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. , 1999, The American journal of medicine.
[284] E. Guthrie,et al. A Randomised Controlled Trial of Psychotherapy in Patients with Refractory Irritable Bowel Syndrome , 1993, British Journal of Psychiatry.
[285] J. Söderholm,et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. , 2002, Gastroenterology.
[286] P. Costa,et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. , 1990, Gastroenterology.
[287] N. Read,et al. Reported Sexual Abuse Predicts Impaired Functioning but a Good Response to Psychological Treatments in Patients With Severe Irritable Bowel Syndrome , 2005, Psychosomatic medicine.
[288] K. Ung,et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis , 2000, Gut.
[289] H X Chen,et al. A population‐based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling , 2004, Alimentary pharmacology & therapeutics.
[290] K. Sandrasegaran,et al. Postinfective Diarrhoea and Bile Acid Malabsorption , 1997, Journal of the Royal College of Physicians of London.
[291] H. Meshkinpour,et al. Role of Anger in Antral Motor Activity in Irritable Bowel Syndrome , 2000, Digestive Diseases and Sciences.
[292] J. Kellow,et al. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. , 1992, Scandinavian journal of gastroenterology.
[293] G. Ardran,et al. Observations on experimentally induced colonic pain. , 1972, Gut.
[294] J. Hunter,et al. FOOD INTOLERANCE: A MAJOR FACTOR IN THE PATHOGENESIS OF IRRITABLE BOWEL SYNDROME , 1982, The Lancet.
[295] F. Hoehler,et al. The Effect of Stress on Colon Motor and Electrical Activity in Irritable Bowel Syndrome , 1985, Psychosomatic medicine.
[296] R. Jones,et al. Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.
[297] M. Bushnell,et al. Pain affect encoded in human anterior cingulate but not somatosensory cortex. , 1997, Science.
[298] P. Whorwell,et al. Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. , 1991, Gut.
[299] E A Mayer,et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome , 1997, Gut.
[300] C. Lunardi,et al. Double‐blind cross‐over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[301] W. Whitehead,et al. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. , 1980, Digestive diseases and sciences.
[302] A. Hoes,et al. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome , 2004, Alimentary pharmacology & therapeutics.
[303] H. Engin,et al. Interleukin-2-induced reversible hyperbilirubinemia and cholestasis in a patient with Gilbert's syndrome , 2002, Journal of gastroenterology.
[304] B. Naliboff,et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia , 2000, PAIN®.
[305] Franz Anton Mesmer. Review article: the history of hypnotherapy and its role in the irritable bowel syndrome , 2005 .
[306] E. Blanchard,et al. The short-term natural history of irritable bowel syndrome: a time-series analysis. , 1997, Behaviour research and therapy.
[307] N. Talley,et al. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? , 1997, The American journal of gastroenterology.
[308] J. Herrerías-Gutiérrez,et al. Altered gastric emptying in patients with irritable bowel syndrome , 1999, European Journal of Nuclear Medicine.
[309] R. Clouse,et al. USE OF PSYCHOPHARMACOLOGICAL AGENTS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS , 2005, Gut.
[310] A. Pfeiffer,et al. Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome. , 1996, Scandinavian journal of gastroenterology.
[311] M. Özkaya,et al. Association of the −1438 G/A and 102 T/C Polymorphism of the 5-Ht2A Receptor Gene with Irritable Bowel Syndrome 5-Ht2A Gene Polymorphism in Irritable Bowel Syndrome , 2004, Journal of clinical gastroenterology.
[312] D. Fuchs,et al. The role of psychological and biological factors in postinfective gut dysfunction , 2000, Gut.
[313] F. Chan,et al. Epidemiology of Irritable Bowel Syndrome in Chinese , 2002, Digestive Diseases and Sciences.
[314] J. Fielding. Domperidone treatment in the irritable bowel syndrome. , 1982, Digestion.
[315] G. Chrousos,et al. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.
[316] S. Ahrné,et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome , 2000, American Journal of Gastroenterology.
[317] N. Read,et al. Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders. , 2005, The British journal of psychiatry : the journal of mental science.
[318] M. Sullivan,et al. Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics. , 1978, The New England journal of medicine.
[319] L. Munck,et al. Irritable bowel syndrome--prognosis and diagnostic safety. A 5-year follow-up study. , 1985, Scandinavian journal of gastroenterology.
[320] J. Svedlund. Psychotherapy in Irritable Bowel Syndrome , 1983 .
[321] B. Amra,et al. Prevalence of irritable bowel syndrome in Shahrekord, Iran. , 2003, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[322] E. Guthrie,et al. A controlled trial of psychological treatment for the irritable bowel syndrome. , 1991, Gastroenterology.
[323] R. Spiller,et al. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. , 2001, The Journal of infectious diseases.
[324] D. Buchwald,et al. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. , 2000, Archives of internal medicine.
[325] G. Lamvu,et al. Long-term outcomes after surgical and nonsurgical management of chronic pelvic pain: one year after evaluation in a pelvic pain specialty clinic. , 2006, American journal of obstetrics and gynecology.
[326] N. Talley,et al. The Irritable Bowel Syndrome: Long-Term Prognosis and the Physician-Patient Interaction , 1995, Annals of Internal Medicine.
[327] A R Zinsmeister,et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. , 1992, Gastroenterology.
[328] M. Dapoigny,et al. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. , 2004, Gastroenterologie clinique et biologique.
[329] J. Vandenbroucke,et al. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. , 1993, Scandinavian journal of gastroenterology. Supplement.
[330] E. Spitznagel,et al. The Association of Irritable Bowel Syndrome and Somatization Disorder , 2001, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[331] A. Morelli,et al. Abnormal Colonic Propagated Activity in Patients with Slow Transit Constipation and Constipation-Predominant Irritable Bowel Syndrome , 2004, Digestion.
[332] R. Awad,et al. Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial. , 1995, Acta gastroenterologica Latinoamericana.
[333] P. Openshaw,et al. Towards positive diagnosis of the irritable bowel. , 1978, British medical journal.
[334] D. Drossman,et al. AGA technical review on irritable bowel syndrome. , 2002, Gastroenterology.
[335] M. Batt,et al. Musculoskeletal Problems of the Chest Wall in Athletes , 2002, Sports medicine.
[336] S. Fullerton,et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. , 1998, The American journal of gastroenterology.
[337] N. Talley,et al. Abdominal wall muscle activity in irritable bowel syndrome with bloating , 2001, American Journal of Gastroenterology.
[338] F. Azpiroz,et al. Modification of small bowel mechanosensitivity by intestinal fat , 2001, Gut.
[339] A. Zinsmeister,et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome , 2003, Alimentary pharmacology & therapeutics.
[340] G. Corazza,et al. Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients , 2006, Gut.
[341] S. Greenfield,et al. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.
[342] W. Whitehead,et al. Hypnosis Treatment for Severe Irritable Bowel Syndrome: Investigation of Mechanism and Effects on Symptoms , 2002, Digestive Diseases and Sciences.
[343] D. V. Reynolds,et al. Surgery in the Rat during Electrical Analgesia Induced by Focal Brain Stimulation , 1969, Science.
[344] D. Drossman,et al. Health status by gastrointestinal diagnosis and abuse history. , 1996, Gastroenterology.
[345] M. Färkkilä,et al. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6‐month intervention , 2005, Alimentary pharmacology & therapeutics.
[346] A. Pizzimenti,et al. Randomized double‐blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM‐IV‐TR pain disorder , 2005, European journal of pain.
[347] G. Gasbarrini,et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. , 1995, Scandinavian journal of gastroenterology.
[348] A. Masclee,et al. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome , 2002, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[349] K. Kendler,et al. A twin-family study of self-report symptoms of panic-phobia and somatization , 1995, Behavior genetics.
[350] S. Morley,et al. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. , 2004, Journal of consulting and clinical psychology.
[351] R JoséKlinger,et al. Irritable Bowel Syndrome , 2006 .
[352] Thomas R. Riley,et al. A Randomized Double-blind Placebo-controlled Trial , 2004 .
[353] K. Klein. Controlled treatment trials in the irritable bowel syndrome: a critique. , 1988, Gastroenterology.
[354] R. Milo. Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome. , 1980, Current medical research and opinion.
[355] A. Roalfe,et al. Prevalence of irritable bowel syndrome: a community survey. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.
[356] P. Whorwell,et al. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness , 2002, American Journal of Gastroenterology.
[357] R. Spiller,et al. Prognosis in post-infective irritable bowel syndrome: a six year follow up study , 2002, Gut.
[358] G. Stein,et al. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo , 1987, Digestive Diseases and Sciences.
[359] X-C Fang,et al. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis , 2004, Gut.
[360] S. Fullerton,et al. Symptom duration in patients with irritable bowel syndrome. , 1996, The American journal of gastroenterology.
[361] A. Dawson,et al. Functional abdominal pain: further evidence that whole gut is affected. , 1982, British medical journal.
[362] S. Rajendra,et al. Prevalence of irritable bowel syndrome in a multi‐ethnic Asian population , 2004, Alimentary pharmacology & therapeutics.
[363] W. Thompson,et al. Placebos: a review of the placebo response , 2000, American Journal of Gastroenterology.
[364] D. Pickens,et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome , 2005, Gut.
[365] S. Riordan,et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. , 1996, The American journal of gastroenterology.
[366] H. Shepherd,et al. Bran supplementation in the treatment of irritable bowel sgndrome , 1994, Alimentary pharmacology & therapeutics.
[367] Nuri Karaman,et al. Irritable bowel syndrome prevalence in city center of Sivas. , 2003, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[368] D. Wingate,et al. THE IRRITABLE BOWEL SYNDROME: A PAROXYSMAL MOTOR DISORDER , 1985, The Lancet.
[369] D. Drossman,et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist , 1999, Alimentary pharmacology & therapeutics.
[370] E. Blanchard,et al. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. , 1995, Journal of consulting and clinical psychology.
[371] W. Chey,et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea , 2000, American Journal of Gastroenterology.
[372] K. Kroenke,et al. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. , 2000, Annals of internal medicine.
[373] A. Turnbull,et al. Corticotropin-Releasing Factor (CRF) and Endocrine Responses to Stress: CRF Receptors, Binding Protein, and Related Peptides , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[374] R. Spiller,et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.
[375] J. Malagelada,et al. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome , 2001, Gut.
[376] L. D. O'Donnell,et al. An office guide to whole-gut transit time. Patients' recollection of their stool form. , 1994, Journal of clinical gastroenterology.
[377] P. Whorwell. Effective Management of Irritable Bowel syndrome—the Manchester Model , 2006, The International journal of clinical and experimental hypnosis.
[378] N. Talley,et al. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population , 1998, Gut.
[379] M. Dunlop,et al. Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years , 2002, Gut.
[380] H. Mardini,et al. Paroxetine to Treat Irritable Bowel Syndrome Not Responding to High-Fiber Diet: A Double-Blind, Placebo-Controlled Trial , 2004, American Journal of Gastroenterology.
[381] C. Ihlebæk,et al. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications , 2004, Alimentary pharmacology & therapeutics.
[382] B. Klapp,et al. Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome , 2003, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[383] D. Drossman,et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. , 2005, Gastroenterology.
[384] X. Badia,et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype , 2003, European journal of gastroenterology & hepatology.
[385] D. Drossman,et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. , 1995, Digestive diseases and sciences.
[386] W. Whitehead,et al. Hypnosis Home Treatment for Irritable Bowel Syndrome: A Pilot Study , 2006, The International journal of clinical and experimental hypnosis.
[387] B. Naliboff,et al. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome , 2001, American Journal of Gastroenterology.
[388] M. Valdovinos,et al. Irritable Bowel Syndrome in Mexico , 2001, Digestive Diseases.
[389] M. Delvaux,et al. Evaluation of colonic sensory thresholds in IBS patients using a barostat , 1994, Digestive Diseases and Sciences.
[390] E. Blanchard,et al. Depression and Abdominal Pain in IBS Patients: The Mediating Role of Catastrophizing , 2004, Psychosomatic medicine.
[391] S. Phillips,et al. Colonic motility in health and disease. , 1996, Gastroenterology clinics of North America.
[392] M. Wong,et al. The Prevalence, Symptom Characteristics, and Impact of Irritable Bowel Syndrome in an Asian Urban Community , 2004, American Journal of Gastroenterology.
[393] D. Bouhassira,et al. Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome , 2004, Gut.
[394] M. Camilleri,et al. Independent influences of body mass and gastric volumes on satiation in humans. , 2004, Gastroenterology.
[395] Mcgill Db,et al. Irritable bowel syndrome. Role of lactase deficiency. , 1983 .
[396] C. Böhmer,et al. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study , 2001, European journal of gastroenterology & hepatology.
[397] G. Bleijenberg,et al. The relationship between complaint-related cognitions in referred patients with irritable bowel syndrome and subsequent health care seeking behaviour in primary care. , 1996, Family practice.
[398] J. Hunter,et al. Effect of Lactobacillus plantarum 299v on Colonic Fermentation and Symptoms of Irritable Bowel Syndrome , 2002, Digestive Diseases and Sciences.
[399] P. Whorwell,et al. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome , 2003, Gut.
[400] P. Vernia,et al. Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. , 1995, The Italian journal of gastroenterology.
[401] M. Pimentel,et al. A 14-Day Elemental Diet Is Highly Effective in Normalizing the Lactulose Breath Test , 2004, Digestive Diseases and Sciences.
[402] Hitoshi Takahashi,et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses , 2004, Acta Neuropathologica.
[403] R. Spiller,et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[404] N. Read,et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. , 2003, Gastroenterology.
[405] J. Barton,et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case–control study , 2003, American Journal of Gastroenterology.
[406] N. Read,et al. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome. , 1983, Gut.
[407] A. Zinsmeister,et al. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[408] J. Kellow,et al. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. , 1998, Gut.
[409] Wang Lh,et al. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis , 2004 .
[410] S. Çelebi,et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society , 2004, Journal of gastroenterology and hepatology.
[411] M. Färkkilä,et al. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population , 2004, Alimentary pharmacology & therapeutics.
[412] B. Spiegel,et al. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. , 2004, Gastroenterology.
[413] Javier Santos,et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[414] P. Whorwell,et al. More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology. , 1991, Gut.
[415] T. S. Lai,et al. Prevalence of irritable bowel syndrome in Hong Kong , 2002, Journal of gastroenterology and hepatology.
[416] D. Burns. The risk of abdominal surgery in irritable bowel syndrome. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[417] Qasim Aziz,et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. , 2006, Gastroenterology.
[418] N. Read,et al. Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome , 2003, Gut.
[419] L. Chang,et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation , 2005, Gut.
[420] E. Blanchard,et al. A multi-component treatment for irritable bowel syndrome , 1987 .
[421] P. Costa,et al. Social learning influences on menstrual symptoms and illness behavior. , 1986, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[422] C. Beglinger,et al. Tegaserod, a 5‐HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects , 2001, Alimentary pharmacology & therapeutics.
[423] R. Spiller,et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome , 2000, Gut.
[424] Stuart W G Derbyshire,et al. A systematic Review of Neuroimaging Data During Visceral Stimulation , 2003, American Journal of Gastroenterology.
[425] Nicholas J. Talley,et al. U. S. Householder survey of functional gastrointestinal disorders , 1993, Digestive Diseases and Sciences.
[426] C. Hunt,et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria , 1999, American Journal of Gastroenterology.